Filing Details
- Accession Number:
- 0001127602-10-002295
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-27 12:00:00
- Reporting Period:
- 2010-01-26
- Filing Date:
- 2010-01-27
- Accepted Time:
- 2010-01-27 15:13:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 799729 | Parexel International Corp | PRXL | Services-Commercial Physical & Biological Research (8731) | 042776269 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1278042 | A Mark Goldberg | Parexel International Corporation 195 West Street Waltham MA 02451 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-01-26 | 10,000 | $8.55 | 126,695 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-01-26 | 5,000 | $19.49 | 121,695 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-01-26 | 5,000 | $21.00 | 116,695 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2010-01-26 | 10,000 | $0.00 | 10,000 | $8.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2012-01-27 | No | 4 | M | Direct |
Footnotes
- The reported sale was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the reporting person.
- Currently Exercisable.
Billionaire Hedge Funds
